VPIM
ANRO icon

Vanguard Personalized Indexing Management’s Alto Neuroscience ANRO Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$352K Sell
15,646
-839
-5% -$15.6K ﹤0.01% 1515
2025
Q4 		$293K Sell
16,485
-560
-3% -$7.05K ﹤0.01% 1534
2025
Q3 		$68.5K Buy
17,045
+2,055
+14% +$6.81K ﹤0.01% 1870
2025
Q2 		$33K Buy
+14,990
New +$35.7K ﹤0.01% 1865

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Personalized Indexing Management's ANRO Position: Q1 2026 in Review

Vanguard Personalized Indexing Management reduced its Alto Neuroscience (ANRO) stake by 5.1% in Q1 2026, selling an estimated $15.6K and leaving 15,646 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #1515.

Vanguard Personalized Indexing Management first reported a position in ANRO in Q2 2025 and has held it in 4 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Vanguard Personalized Indexing Management held 15,646 shares of Alto Neuroscience worth $352K as of Q1 2026.
  • Vanguard Personalized Indexing Management sold 839 Alto Neuroscience shares in Q1 2026, an estimated $15.6K.
  • Alto Neuroscience made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #1515 holding.
  • Vanguard Personalized Indexing Management first reported a position in Alto Neuroscience in Q2 2025 and has held it in 4 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.